2106-38-9Relevant academic research and scientific papers
PHARMACEUTICAL COMPOUNDS
-
Page/Page column 37-38, (2010/02/14)
The present invention relates to inhibitors of serotonin and/or norepinephrine reuptake and specifically provides compounds of formula (I): wherein A is selected from -O- and -S-; X is selected from C1-C8 alkyl, C2-C8 alkenyl, and C4-C8 cycloalkylalkyl, each of which may be optionally substituted with up to 3 substituents each independently selected from phenyl, pyrrolidinyl, piperidinyl, morpholinyl, halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, -CF3, -CN and -CONH2; Y is selected from (a), (b), (c), (d), (e), (f) where R3, R4and R5 are independently selected from hydrogen, halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, nitro, acetyl, -CF3, -SCF3 and cyano; R6 and R7 are independently selected from halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, nitro, acetyl, -CF3, -SCF3 and cyano; R8 is selected from chloro, bromo, iodo, C1-C4alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, nitro, acetyl, -CF3, -SCF3 and cyano; R1 and R2 are each independently hydrogen or C1-C4 alkyl; or pharmaceutically acceptable salts thereof; or compositions thereof and methods of using the same.
Crown Cation Complex Effects. 12. Dissolution and Complexation of Arenediazonium Cations in Nonpolar Media. An Assessment of Solvent Effects and Reactivity by Infrared and Nuclear Magnetic Resonance Spectroscopy
Korzeniowski, Stephen H.,Leopold, Ahuva,Beadle, James R.,Ahern, Michael F.,Sheppard, William A.,et al.
, p. 2153 - 2159 (2007/10/02)
A number of arenediazonium salts (largely tetrafluoroborates) have been surveyed to determine their solubility properties and the influence of crown ethers and quaternary ammonium salts thereupon.Analysis has been by a variety of spectral techniques inclu
